Nalagenetics Pte Ltd   Report issue

For profit
Founded: papua Indonesia (2016)

Organization Overview

First Clinical Trial
2019
NCT04312347
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Nalagenetics Pte Ltd

Active Ingredients

Drugs in Other Trials (1)

tamoxifen (nolvadex) (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 1